UCSF CME Interstitial Lung Disease: The Changing Landscape

A new registration system was installed in January 2020. Account holders who registered prior to January 2020, please choose New Customers, to Create a New Account. All others please login to your account to enroll in this course.

Please do not create multiple accounts. If you have forgotten your password, please choose "Login to Existing Account" then choose "Forgot Password."

COVID-19 Guidelines

exhibitors


Overview Objectives Accreditation Course Outline
Chairs Faculty Travel & Lodging Cancellation Policy

Department: Pulmonary, Critical Care, Allergy and Sleep Medicine
Course Number: MCT24002
Activity Start Date: January 27, 2024
Activity End Date: January 27, 2024
Location:

Mission Bay Conference Center
San Francisco CA

Fees:

Early Bird Ends- December 27th, 2023
Physicians $350.00
Allied Health Professionals $250.00
Residents/Fellows $150.00

Regular Fee Begin- December 27th, 2023
Physicians $375.00
Allied Health Professionals $275.00
Residents/Fellows $175.00

 

Overview:

Interstitial lung disease (ILD) is a disease category that encompasses dozens of pathobiologically distinct conditions, and it poses substantial challenges to the practicing physician. There is considerable confusion in the medical community regarding the diagnosis and management of ILD resulting in significant delays in diagnosis and treatment. Treatment options are rapidly evolving with the development of new medications, completion of large clinical trials in various forms of ILD, and an evolving understanding of the role of genetics and environment on disease progression and management. In addition, there is growing recognition that interstitial lung abnormalities (ILAs), or incidental radiologic abnormalities on chest CT that are potentially related to ILD, require special consideration and follow-up as they have been associated with radiologic progression, increased rate of a clinical diagnosis of ILD, and increased rate of mortality. Therefore, this course is designed to provide an up-to-date framework for the diagnosis, management, and monitoring of ILD and to introduce practitioners to the evolving landscape of defining, monitoring, and studying ILAs. 

TARGET AUDIENCE
This conference is designed to provide clinicians and other health care providers with a practical approach to the diagnosis and management of ILD, an understanding of the importance of accurate and timely diagnosis, and a treatment approach that is comprehensive and evidence-based.

Back To Top


Objectives:

This course is designed to improve the ability of providers to:

Back To Top


Accreditation:

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Back To Top


Course Outline:

January 27, 2024
8:00AM Registration and Continental Breakfast
8:00 Welcome and Pre-Test Jeff Golden, MD
8:10 Navigating the Latest: Clinical Updates in Interstitial Lung Disease Rupal J. Shah, MD
8:40 Translating Images into Answers: Radiology's Approach to ILD Brett M. Elicker, MD
9:20 The Language of Cells: Pathological Insights into ILD Kirk D. Jones, MD
10:00 Break
10:15 Interstitial Lung Abnormalities: Designing early-stage pulmonary fibrosis prevention trials. Gary “Matt” Hunninghake, MD
11:00 Case Presentations: Multidisciplinary Discussion in Action Max Cohen, MD & Angela Suen, MD
12:00PM Lunch
1:00 Unlocking the Toolbox: Pharmacological Interventions in ILD Leah Witt, MD
1:30 Connected Care: Exploring Home Monitoring for Interstitial Lung Disease  Erica Farrand, MD
2:00 Lung Transplantation: Special Considerations in Candidates with ILD Aida Venado Estrada, MD
2:30 Break
2:45 Two Conditions, One Battle: ILD and Pulmonary Hypertension Nick Kolaitis, MD
3:15 Inherited Insights: Understanding the Genetic Basis of ILD Paul Wolters, MD
3:45 Health Equity and ILD: Uncovering Disparities in Lung Health Alison DeDent, MD
4:15 Panel Discussion and Q&A All Faculty
4:45 Post-test and Closing Remarks Jeff Golden, MD
5:00 Adjourn 

 


Back To Top


Course Co-Chairs:

Rupal Shah, MD, MS
Associate Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

Erica Farrand, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

Back To Top



Faculty

Alison DeDent, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

Brett Elicker, MD
Professor of Radiology
Chief of Cardiac & Pulmonary Imaging

Jeffrey Golden, MD
Professor of Medicine
Associate Medical Director, Lung Transplant Program

Kirk D. Jones, MD
Professor of Medicine
Departments of Pathology and Laboratory Medicine

Nicholas Kolaitis, MD, MAS
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

Aida Venado Estrada, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

Leah Witt, MD
Assistant Professor of Medicine, Pulmonary Associate Chief for Ambulatory Affairs Fellowship
Coach, Pulmonary & Critical Care Medicine Fellowship Program

Paul Wolters, MD
Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine

Guest Faculty

Gary “Matt” Hunninghake, MD MPH
Associate Professor of Medicine, Harvard Medical School
Director, Interstitial Lung Disease Program, Brigham and Women’s Hospital

 

Back To Top


Travel & Lodging:

Mission Bay Conference Center
1675 Owens Street
San Francisco CA 94143
Hotel Phone: 415-476-2019

 

UNITED AIRLINES
UCSF has negotiated special fares with United Airlines for our course attendees.
Download Online Booking Instructions (.pdf)
Code ZNRW982350

Back To Top


Cancellation Policy:

Cancellations received in writing before January 26, 2023 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.

Please email your requests to RegEmail@ucsf.edu

Back To Top